HealthQuill Articles by: HealthQuill
Families of patients with severe traumatic brain injury will have to think twice before plugging out the life support systems of their near ones as a study cited “poor neurologic prognosis” by physicians as the main reason for withdrawing the breathing aid.
Drugs Health Pharma

Jury out on when to unplug life-support for patients with brain injury

HQ Team May 14, 2024: Families of patients with severe traumatic brain injury will have to think twice before plugging out the life

Read More
Factors like the patient’s character, carer’s personality and attitude towards the patient, relationship between the carer and patient, time spent together, and the severity of the illness impact the intensity of the caregiver burden.
Drugs Health Opinion Pharma

Opinion: Who will worry about caregivers for the mentally ill?

By Aparna S May 14, 2024: A caregiver is a person who takes care of and provides for another individual who cannot take

Read More
BioNTech signs pact with Australia
Drugs Health Medical

Covid-19 vaccines increase life expectancy of heart patients, study

HQ Team May 13, 2024:  New research says Covid-19 vaccines given to people suffering from heart failure improve their chances of living longer

Read More
The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer.
Drugs Medical Pharma

Merck discontinues trial for combo cancer drug for melanoma

HQ Team May 13, 2024: Merck has discontinued another cancer experimental immunotherapy treatment in patients with a severe form of melanoma due to

Read More
Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance Minister Bruno Le Maire said, according to a publicly-funded television network, France 24.
Drugs Health Pharma

Pfizer, AstraZeneca to invest close to $1 billion in France to expand

HQ Team May 13, 2024: Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance

Read More
The world’s tropics lost 4.1 million hectares of forests, the equivalent of 11 soccer fields, every minute in 2022, according to the World Resources Institute.
Climate Health Medical

Unauthorised ghost roads in tropical forests raising fears of deforestation

HQ Team May 10, 2024: There are many unauthorised roads in tropical forests than what is shown in official records. This has raised

Read More
overuse of cannabis can result in impaired memory
Drugs Health Medical

Preoperative botox jabs may help identify migraine trigger sites

HQ Team May 10, 2024: Botox has been traditionally used to treat migraine, but there is not enough data available to prove its

Read More
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received Breakthrough Therapy Designation from the USFDA.
Drugs Health Pharma

Merck’s end-stage trials of endometrial cancer therapy fail to meet goals

HQ Team May 9, 2024: Merck announced that its Phase 3 trial evaluating Keytruda therapy in combination with chemotherapy, with or without radiotherapy,

Read More
Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to 59 years has met its primary goals in trials.
Drugs Health Medical

Early assessment can predict cerebral palsy severity in infants

Early neurodevelopmental assessments can predict cerebral palsy and its severity in infants, according to an Australian study. Researchers at Monash University in Melbourne

Read More
A young boy, treated for a rare genetic disease, died during a mid-stage clinical trial conducted by Pfizer, according to a statement posted by a non-profit group on its website quoting a company statement.
Drugs Health Pharma

Boy dies during Pfizer’s clinical trial probing rare genetic disease

HQ Team May 8, 2024: A young boy, treated for a rare genetic disease, died during a mid-stage clinical trial conducted by Pfizer,

Read More